Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)

被引：0
|
作者：
Smyth, E. C.
Janjigian, Y. Y.
Robinson, E.
Sheehy, E. C.
Karpenko, I.
Capanu, M.
Kelsen, D. P.
Shah, M. A.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy cancer and adenocarcinoma of in advanced gastric the gastroesophageal junction: results of a phase II trial
    Lorenzen, S.
    Hentrich, M.
    Haberi, C.
    Heinemann, V.
    Schuster, T.
    Seroneit, T.
    Roethling, N.
    Peschel, C.
    Lordick, F.
    ANNALS OF ONCOLOGY, 2007, 18 (10) : 1673 - 1679
  • [42] A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction
    McNamara, Michael J.
    Adelstein, David J.
    Bodmann, Joanna W.
    Greskovich, John F., Jr.
    Ives, Denise I.
    Mason, David P.
    Murthy, Sudish C.
    Rice, Thomas W.
    Saxton, Jerrold P.
    Sohal, Davendra
    Stephans, Kevin
    Rodriguez, Cristina P.
    Videtic, Gregory M. M.
    Rybicki, Lisa A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : 1561 - 1567
  • [43] Efficacy of pegfilgrastim administration in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
    Yoshida, Y.
    Komori, K.
    Aoki, M.
    Sandou, M.
    Takagi, M.
    Uejima, E.
    PHARMAZIE, 2018, 73 (10): : 613 - 616
  • [44] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL CHEMOTHERAPY IN YOUNG KOREAN PATIENTS WITH ADVANCED GASTRIC CANCER
    Shim, H.
    Cho, M.
    Park, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 88 - 88
  • [45] Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer
    Lin, Jen-Tsun
    Lai, Guam-Min
    Chang, Tung-Hao
    Liu, Mu-Tai
    Bi, Chu-Ping
    Wang, Jer-Wei
    Chen, Mu-Kuan
    ADVANCES IN THERAPY, 2012, 29 (01) : 71 - 77
  • [46] Chemotherapy with Modified Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Metastatic Head and Neck Cancer
    Jen-Tsun Lin
    Guam-Min Lai
    Tung-Hao Chang
    Mu-Tai Liu
    Chu-Ping Bi
    Jer-Wei Wang
    Mu-Kuan Chen
    Advances in Therapy, 2012, 29 : 71 - 77
  • [47] Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
    Nuriye Ozdemir
    Huseyin Abali
    Murat Vural
    Suayib Yalcin
    Berna Oksuzoglu
    Burak Civelek
    Dilek Oguz
    Birol Bostanci
    Bulent Yalcin
    Nurullah Zengin
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1139 - 1147
  • [48] Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction
    Bar Sela, G
    Tsalic, M
    Gaitini, D
    Steiner, M
    Haim, N
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (06) : 623 - 626
  • [49] Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma
    Monisha Sudarshan
    Thierry Alcindor
    Steven Ades
    Abdullah Aloraini
    Marie van Huyse
    Jamil Asselah
    Marc David
    Dominique Frechette
    Sonia Brisson
    Michael Thirlwell
    Lorenzo Ferri
    Annals of Surgical Oncology, 2015, 22 : 324 - 330
  • [50] Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
    Ozdemir, Nuriye
    Abali, Huseyin
    Vural, Murat
    Yalcin, Suayib
    Oksuzoglu, Berna
    Civelek, Burak
    Oguz, Dilek
    Bostanci, Birol
    Yalcin, Bulent
    Zengin, Nurullah
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1139 - 1147
12345